Yuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula, Muskaan Sachdeva, Khalad Maliyar, Jorge R. Georgakopoulos, & Jensen Yeung. (2022). Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. MDPI AG.
Chicago Style (17th ed.) CitationYuliya Lytvyn, Asfandyar Mufti, Abrahim Abduelmula, Muskaan Sachdeva, Khalad Maliyar, Jorge R. Georgakopoulos, and Jensen Yeung. Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. MDPI AG, 2022.
MLA (9th ed.) CitationYuliya Lytvyn, et al. Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review. MDPI AG, 2022.
Warning: These citations may not always be 100% accurate.